FDA Inspection
Kalyan R. Bhamidimarri MDKalyan R. Bhamidimarri MD – FDA Inspection, Jan 16, 2020
Record Details
This FDA Inspection record concerns Kalyan R. Bhamidimarri MD, with an inspection on January 16, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Kalyan R. Bhamidimarri MD
- Inspection Date
- January 16, 2020
- Product Type
- Drugs
View Company Profile
ID · 8c3cde90-3c4e-4b8a-9d5e-bd213929bf9e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115385
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Unanticipated problems
- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.